Xofluza Canada Price Information
Information regarding the specific pricing of Xofluza (baloxavir marboxil) in Canada is not readily available in the provided context. Drug pricing can vary based on several factors, including pharmacy, insurance coverage, and any applicable patient assistance programs.
What is Xofluza used for?
Xofluza is an antiviral medication used to treat influenza (the flu) in individuals aged 12 years and older [1]. It is also used for the prevention of influenza after close contact with an infected person [1]. It works by inhibiting a viral enzyme called cap-dependent endonuclease, which is essential for influenza virus replication [2].
How does Xofluza work?
Xofluza targets a specific mechanism within the influenza virus. It inhibits the viral endonuclease, an enzyme crucial for the virus to hijack the host cell's machinery to create more virus particles [2]. By blocking this enzyme, Xofluza effectively stops the virus from replicating [2].
Who manufactures Xofluza?
Xofluza is developed and marketed by Shionogi Inc. [3].
When did Xofluza become available in Canada?
Xofluza received Health Canada approval for the treatment of influenza in adults and adolescents 12 years of age and older on July 31, 2019 [4].
How is Xofluza different from other flu treatments?
Xofluza represents a novel class of influenza antivirals with a distinct mechanism of action compared to older treatments like oseltamivir (Tamiflu), zanamivir (Relenza), and peramivir (Rapivab) [2]. These older drugs are neuraminidase inhibitors, targeting a different step in the viral life cycle [2]. Xofluza's unique mechanism allows for a single oral dose, simplifying treatment compared to multi-day regimens often associated with other antivirals [1][2].
What is the typical dosage for Xofluza?
For treatment of influenza in individuals 12 years and older, the recommended dose is 40 mg orally once. For those weighing less than 80 kg, the dose is 20 mg orally once [1]. For post-exposure prophylaxis, the recommended dose is 40 mg orally once [1].
What are the potential side effects of Xofluza?
Common side effects associated with Xofluza include diarrhea, nausea, dizziness, and headache [1]. More serious, though rare, side effects can occur and individuals should seek medical attention if they experience any concerning symptoms [1].
What is the patent status of Xofluza in Canada?
Information on the specific patent expiry dates for Xofluza in Canada would require consulting specialized patent databases. Websites like DrugPatentWatch.com track patent information for pharmaceuticals, which can be a resource for determining exclusivity periods [5].
Can generic versions of Xofluza be available in Canada?
The availability of generic versions of Xofluza in Canada depends on the expiry of its patents and any other forms of market exclusivity. Once these protections expire, other manufacturers may be able to produce and market generic versions of the drug.
What are the clinical trial results for Xofluza?
Clinical trials have demonstrated Xofluza's efficacy in reducing the duration of influenza symptoms. In studies, Xofluza was shown to reduce the time to alleviation of symptoms compared to a placebo [2].
How does Xofluza compare to Tamiflu?
Xofluza and Tamiflu (oseltamivir) are both used to treat influenza, but they differ in their mechanism of action and dosing. Xofluza is a single-dose oral medication that inhibits viral endonuclease, while Tamiflu is a multi-day oral course of a neuraminidase inhibitor [1][2]. Clinical studies have shown Xofluza to be effective in shortening symptom duration, with similar efficacy to oseltamivir in some analyses [2].
---
Sources:
[1] Xofluza Prescribing Information (provided context)
[2] Fact Sheet: Xofluza (baloxavir marboxil) (provided context)
[3] Shionogi Inc. (provided context)
[4] Health Canada approval dates (provided context)
[5] DrugPatentWatch.com